EUVIMEDEUVIMED entdecken
Leserbrief

JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease

Satoshi Fujita, Shigenori Kabashima, Kumiko Yanagi, Kenji Toyokuni, Kazue Yoshida, Yumiko Miyaji, Shuji Takada, Kenichiro Motomura, Masato Tamari, Hisataka Nakazaki, Yuka Hayashi, Naoko Nagano und 14 weitere

Journal of Allergy and Clinical Immunology · 2025-12 · 156 (6) · 1769-1771

DOI: 10.1016/j.jaci.2025.09.012 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-12. Verfasst von Satoshi Fujita und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan; Department of Pediatrics, …. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: National Center for Child Health and Development, Otsuka Pharmaceutical, Government of Japan Ministry of Health Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

JAK1alopecia areataatopic dermatitisautoimmune thyroid diseaseinborn errors of immunity

Autor:innen und Institutionen

  • Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan; Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan.
  • Allergy Center, National Center for Child Health and Development, Tokyo, Japan.
  • Department of Genome Medicine, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Allergy Center, National Center for Child Health and Development, Tokyo, Japan; Division of Dermatology, National Center for Child Health and Development, Tokyo, Japan.
  • Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan; Division of Immuno-Biomedical Research, Integrated Center for Women's Health, National Center fo…

Förderung

  • National Center for Child Health and Development
  • Otsuka Pharmaceutical
  • Government of Japan Ministry of Health Labour and Welfare
  • Japan Agency for Medical Research and Development
  • GlaxoSmithKline

Zitieren

APA

Fujita, S., Kabashima, S., Yanagi, K., Toyokuni, K., Yoshida, K., Miyaji, Y., Takada, S., Motomura, K., Tamari, M., Nakazaki, H., Hayashi, Y., Nagano, N., Uchiyama, T., Oishi, K., Yokoya, S., Yoshioka, T., Tanase-Nakao, K., Yamamoto-Hanada, K., Fukuie, T., …, & Morita, H. (2025). JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease. Journal of Allergy and Clinical Immunology, 156(6), 1769-1771. https://doi.org/10.1016/j.jaci.2025.09.012

Vancouver

Fujita S, Kabashima S, Yanagi K, Toyokuni K, Yoshida K, Miyaji Y, et al. JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease. Journal of Allergy and Clinical Immunology. 2025;156(6):1769-1771. doi:10.1016/j.jaci.2025.09.012

BibTeX
@article{Fujita2025,
  author = {Fujita, Satoshi and Kabashima, Shigenori and Yanagi, Kumiko and Toyokuni, Kenji and Yoshida, Kazue and Miyaji, Yumiko and Takada, Shuji and Motomura, Kenichiro and Tamari, Masato and Nakazaki, Hisataka and Hayashi, Yuka and Nagano, Naoko and Uchiyama, Toru and Oishi, Kimihiko and Yokoya, Susumu and Yoshioka, Takako and Tanase-Nakao, Kanako and Yamamoto-Hanada, Kiwako and Fukuie, Tatsuki and Horikawa, Reiko and Saito, Hirohisa and Matsubara, Yoichi and Ohya, Yukihiro and Kaname, Tadashi and Matsumoto, Kenji and Morita, Hideaki},
  title = {JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2025},
  volume = {156},
  number = {6},
  pages = {1769--1771},
  doi = {10.1016/j.jaci.2025.09.012}
}
Kostenlos starten →